FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387206632> ?p ?o ?g. }

• W4387206632 endingPage "e126" @default.
• W4387206632 startingPage "e125" @default.
• W4387206632 abstract "This study aimed to develop a graded prognostic assessment (GPA) model integrating genomic characteristics in patients with elderly glioblastoma (eGBM), and compare the efficacy between conventionally fractionated radiotherapy (CFRT) vs. hypofractionated radiotherapy (HFRT) in each risk group.Patients aged ≥65 years who underwent surgical resection followed by radiotherapy (RT) with or without temozolomide (TMZ) for newly diagnosed IDH-wildtype eGBM between 2006 and 2021 were included in this multicenter cohort study. Patients who were planned for a ≥6-week or ≤4-week radiotherapy were regarded as being treated with CFRT or HFRT, respectively. Based on the prognostic factors significantly identified through multivariate analysis for overall survival (OS), we developed the molecular GPA for eGBM (eGBM-molGPA) and assigned 0.0, 0.5, and 1.0 points in proportion to the corresponding hazard ratio (HR) of each factor. Then, the survival outcomes by treatment groups were evaluated according to the eGBM-molGPA scores.A total of 334 and 239 patients who underwent CFRT and HFRT were included, respectively, and 86% of patients were treated with TMZ-based chemoradiation. With a median follow-up of 17.4 months for survivors, the median OS was 18.7 months for CFRT plus TMZ group, 15.1 months for HFRT plus TMZ group, and 10.4 months for RT alone group, respectively (all p<0.001). In the multivariate analysis, Karnofsky performance scale, surgical extent, TMZ, and the methylation status of the MGMT promoter were identified as strong prognostic factors for OS, with an estimated HR of greater than 1.5 (all p<0.001). Additionally, subventricular zone involvement, temporalis muscle thickness, RT regimen, and the mutation status of TERT promoter and TP53 gene were found to be significant prognostic factors for OS, with an estimated HR of less than 1.5. The eGBM-molGPA was established based on these prognostic factors (Table 1) and patients were allocated to three risk groups, which included high risk (total score of 3.0-4.5), intermediate risk (1.5-2.5), and low risk (0.0-1.0). Patients treated with CFRT plus TMZ had significantly improved OS compared to those treated with HFRT plus TMZ or RT alone in the low and intermediate risk groups (p<0.001). However, in the high-risk group, there was no significant difference in OS between treatment options (p = 0.770).CFRT plus TMZ can be a more effective strategy for selected eGBM patients compared to HFRT. For high-risk patients, a protracted treatment schedule might not be beneficial. The novel eGBM-molGPA can be used as a clinical tool for choosing wisely among treatment options. Further prospective studies are warranted to establish optimal RT guidelines for eGBM patients." @default.
• W4387206632 created "2023-09-30" @default.
• W4387206632 creator A5016142912 @default.
• W4387206632 creator A5048005267 @default.
• W4387206632 creator A5048386396 @default.
• W4387206632 creator A5051305073 @default.
• W4387206632 creator A5053386417 @default.
• W4387206632 creator A5069137747 @default.
• W4387206632 creator A5084782886 @default.
• W4387206632 date "2023-10-01" @default.
• W4387206632 modified "2023-10-17" @default.
• W4387206632 title "Choosing Wisely between Radiotherapy Dose-Fractionation Schedules: The Molecular Graded Prognostic Assessment (molGPA) for Elderly Glioblastoma (eGBM-molGPA)" @default.
• W4387206632 doi "https://doi.org/10.1016/j.ijrobp.2023.06.919" @default.
• W4387206632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784678" @default.
• W4387206632 hasPublicationYear "2023" @default.
• W4387206632 type Work @default.
• W4387206632 citedByCount "0" @default.
• W4387206632 crossrefType "journal-article" @default.
• W4387206632 hasAuthorship W4387206632A5016142912 @default.
• W4387206632 hasAuthorship W4387206632A5048005267 @default.
• W4387206632 hasAuthorship W4387206632A5048386396 @default.
• W4387206632 hasAuthorship W4387206632A5051305073 @default.
• W4387206632 hasAuthorship W4387206632A5053386417 @default.
• W4387206632 hasAuthorship W4387206632A5069137747 @default.
• W4387206632 hasAuthorship W4387206632A5084782886 @default.
• W4387206632 hasConcept C126322002 @default.
• W4387206632 hasConcept C141071460 @default.
• W4387206632 hasConcept C143998085 @default.
• W4387206632 hasConcept C207103383 @default.
• W4387206632 hasConcept C2776194525 @default.
• W4387206632 hasConcept C2777389519 @default.
• W4387206632 hasConcept C38180746 @default.
• W4387206632 hasConcept C44249647 @default.
• W4387206632 hasConcept C502942594 @default.
• W4387206632 hasConcept C509974204 @default.
• W4387206632 hasConcept C71924100 @default.
• W4387206632 hasConcept C72563966 @default.
• W4387206632 hasConcept C90924648 @default.
• W4387206632 hasConceptScore W4387206632C126322002 @default.
• W4387206632 hasConceptScore W4387206632C141071460 @default.
• W4387206632 hasConceptScore W4387206632C143998085 @default.
• W4387206632 hasConceptScore W4387206632C207103383 @default.
• W4387206632 hasConceptScore W4387206632C2776194525 @default.
• W4387206632 hasConceptScore W4387206632C2777389519 @default.
• W4387206632 hasConceptScore W4387206632C38180746 @default.
• W4387206632 hasConceptScore W4387206632C44249647 @default.
• W4387206632 hasConceptScore W4387206632C502942594 @default.
• W4387206632 hasConceptScore W4387206632C509974204 @default.
• W4387206632 hasConceptScore W4387206632C71924100 @default.
• W4387206632 hasConceptScore W4387206632C72563966 @default.
• W4387206632 hasConceptScore W4387206632C90924648 @default.
• W4387206632 hasIssue "2" @default.
• W4387206632 hasLocation W43872066321 @default.
• W4387206632 hasLocation W43872066322 @default.
• W4387206632 hasOpenAccess W4387206632 @default.
• W4387206632 hasPrimaryLocation W43872066321 @default.
• W4387206632 hasRelatedWork W2022976025 @default.
• W4387206632 hasRelatedWork W2036862336 @default.
• W4387206632 hasRelatedWork W2096287682 @default.
• W4387206632 hasRelatedWork W2185575684 @default.
• W4387206632 hasRelatedWork W2599750069 @default.
• W4387206632 hasRelatedWork W2740663609 @default.
• W4387206632 hasRelatedWork W3031751345 @default.
• W4387206632 hasRelatedWork W3032872084 @default.
• W4387206632 hasRelatedWork W3173223947 @default.
• W4387206632 hasRelatedWork W3194058763 @default.
• W4387206632 hasVolume "117" @default.
• W4387206632 isParatext "false" @default.
• W4387206632 isRetracted "false" @default.
• W4387206632 workType "article" @default.